Grants and Contributions:
Title:
Benchmarking of a novel CAR-T approach: treatment efficacy, functionality, and durability
Agreement Number:
989071
Agreement Value:
$74,256.00
Agreement Date:
Apr 8, 2022 - Dec 31, 2023
Description:
In this project, we will analyze the performance of two novel CAR constructs against the current standard of care CAR construct within physiologically relevant mouse models to demonstrate superior treatment outcomes and durability.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2S 2R8
Reference Number:
172-2022-2023-Q1-989071
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
711826271
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 289 days. The total amended value is 28,392 dollars.
Amendment Date
Dec 14, 2022
Recipient's Legal Name:
12343096 CANADA INC.
Federal Riding Name:
Rosemont--La Petite-Patrie
Federal Riding Number:
24064
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: